Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial
Bruno François(Inserm), Alain Lepape(Hospices Civils de Lyon), Tomáš Suchý, Vincent Huberlant(Centre Hospitalier Universitaire de Nantes), Herman Goossens(University of Antwerp), Filip Dubovsky(University of Maryland, Baltimore), Jan Pachl(Charles University), Alexey Ruzin(AstraZeneca (United States)), Leen Timbermont(Ghent University), Miguel Sánchez García(Hospital Clínico San Carlos), Martin Nováček, Terramika Bellamy(AstraZeneca (United States)), Cédric Bretonnière(Inserm), Christine Lammens(Antwerp University Hospital), Olivier Barraud(Inserm), Jacques Créteur, Frédéric Forêt(Assistance Publique – Hôpitaux de Paris), Frank E. J. Coenjaerts(Utrecht University), Alain Dive, Didier Chochrad(Centre hospitalier Etterbeek-Ixelles), Martin Balík(Charles University), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Michal Hanauer, Yves Bouckaert, Marc J. M. Bonten(Utrecht University), Jérôme Pugin(University Hospital of Geneva), Pin Ren(AstraZeneca (United States)), Petr Svoboda(Ministry of Health), Kathryn Shoemaker(AstraZeneca (United States)), Ana Catalina Hernandez Padilla(Inserm), Hasan S. Jafri(AstraZeneca (Australia)), Susan Colbert(AstraZeneca (United States)), Philippe Eggimann(University Hospital of Lausanne), Marc Bourgeois(AZ Sint-Jan), Vladimír Šrámek, Marc A. Simon(Clinique Saint-Joseph), Tomas Hruby, Mark T. Esser(AstraZeneca (United States)), Tomáš Vymazal, Herbert Spapen(Universitair Ziekenhuis Brussel), Pierre‐François Dequin(Université de Tours), Omar Ali(AstraZeneca (United States)), Josep Trenado(Mútua Terrassa), Yuling Wu(AstraZeneca (United States)), Lucía Viña Soria(Hospital Universitario Central de Asturias), Jean Chastre(Inserm), Vadryn Pierre(AstraZeneca (United States)), Thierry Boulain(Centre hospitalier universitaire d'Orléans), Julie Vignaud(Inserm), Patrick Biston(Grand Charleroi Hospital)
Cited by 88
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
|The Lancet|2005|3.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k